Rights and permissions
About this article
Cite this article
Zelrix and Levadex would be drugs of choice if priced better. Pharmacoecon. Outcomes News 638, 11 (2011). https://doi.org/10.2165/00151234-201106380-00033
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-201106380-00033